02 April 2018

[Reminder] Changes In The Mode Of Dispensing Of The Medicine (Atomoxetine)

Reference: CIR-2018-SHN0841

To: All Health Facilities - Private Sector /Dubai

In accordance with the recommendations of the Ministry of Health and Prevention (MOHP) and on the security and safety of society and 

for the preservation of Public Health and recommendations of the Higher Committee for Registration and Drug Pricing meeting No. 129/2018 (25/02/2018) 

and directions of MOHP and laws to regulate the consumption, distribution and dispensing of medications, Narcotic drugs, Psychotropic substances , Controlled and Semi-Controlled drugs, 

it has been decided to amend the method of dispensing of the above-mentioned drug category to a Semi-Controlled Drug (SCD). 

All health facilities must therefore adhere to this circular in accordance with the instructions in this regard.

§  To avoid any violations or penalties all healthfacilities must adhere to this Circular in accordance with the instructions in this regard.

Telephone: 045022901 or 04- 5022996

 

        Email address:  regulation@dha.gov.ae

For full access on circular # 141, please refer to the following link:

https://www.dha.gov.ae/Documents/Atomoxetine%20Circular%D8%AA%D8%B9%D9%85%D9%8A%D9%85%20%D8%B1%D9%82%D9%85%20141.pdf

with regards/ Health Regulation Department
 

Supporting Documents:

Atomoxetine Circularتعميم رقم 141.pdf:

View Document